vs

Side-by-side financial comparison of MILESTONE SCIENTIFIC INC. (MLSS) and Nuvve Holding Corp. (NVVE). Click either name above to swap in a different company.

MILESTONE SCIENTIFIC INC. is the larger business by last-quarter revenue ($2.1M vs $1.9M, roughly 1.1× Nuvve Holding Corp.). MILESTONE SCIENTIFIC INC. runs the higher net margin — -53.0% vs -314.5%, a 261.5% gap on every dollar of revenue. On growth, Nuvve Holding Corp. posted the faster year-over-year revenue change (7.9% vs 2.2%). Over the past eight quarters, Nuvve Holding Corp.'s revenue compounded faster (8.3% CAGR vs -4.3%).

Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Nuvve Holding Corp. is a global technology provider specializing in vehicle-to-grid (V2G) solutions for electric vehicles. It delivers intelligent energy management platforms that allow EV batteries to feed excess stored power back to electrical grids, serving commercial fleet operators, utility firms, and residential EV owners across North America, Europe, and Asia-Pacific.

MLSS vs NVVE — Head-to-Head

Bigger by revenue
MLSS
MLSS
1.1× larger
MLSS
$2.1M
$1.9M
NVVE
Growing faster (revenue YoY)
NVVE
NVVE
+5.7% gap
NVVE
7.9%
2.2%
MLSS
Higher net margin
MLSS
MLSS
261.5% more per $
MLSS
-53.0%
-314.5%
NVVE
Faster 2-yr revenue CAGR
NVVE
NVVE
Annualised
NVVE
8.3%
-4.3%
MLSS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MLSS
MLSS
NVVE
NVVE
Revenue
$2.1M
$1.9M
Net Profit
$-1.1M
$-6.1M
Gross Margin
73.0%
Operating Margin
-52.5%
-346.7%
Net Margin
-53.0%
-314.5%
Revenue YoY
2.2%
7.9%
Net Profit YoY
46.4%
-19.0%
EPS (diluted)
$-69.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MLSS
MLSS
NVVE
NVVE
Q4 25
$2.1M
$1.9M
Q3 25
$2.4M
$1.6M
Q2 25
$2.3M
Q1 25
$2.2M
$934.3K
Q4 24
$2.0M
$1.8M
Q3 24
$2.5M
$1.9M
Q2 24
$1.9M
$802.2K
Q1 24
$2.2M
$779.8K
Net Profit
MLSS
MLSS
NVVE
NVVE
Q4 25
$-1.1M
$-6.1M
Q3 25
$-1.2M
$-4.5M
Q2 25
$-1.5M
Q1 25
$-2.0M
$-6.9M
Q4 24
$-2.0M
$-5.1M
Q3 24
$-1.5M
$-1.6M
Q2 24
$223.6K
$-3.9M
Q1 24
$-1.4M
$-6.7M
Gross Margin
MLSS
MLSS
NVVE
NVVE
Q4 25
73.0%
Q3 25
69.5%
Q2 25
69.6%
Q1 25
73.8%
Q4 24
75.0%
Q3 24
73.0%
Q2 24
76.1%
Q1 24
74.5%
Operating Margin
MLSS
MLSS
NVVE
NVVE
Q4 25
-52.5%
-346.7%
Q3 25
-48.1%
-319.7%
Q2 25
-63.9%
Q1 25
-89.5%
-597.9%
Q4 24
-101.4%
-314.2%
Q3 24
-58.4%
-95.8%
Q2 24
-96.0%
-718.5%
Q1 24
-65.1%
-929.4%
Net Margin
MLSS
MLSS
NVVE
NVVE
Q4 25
-53.0%
-314.5%
Q3 25
-48.9%
-281.9%
Q2 25
-63.8%
Q1 25
-89.3%
-735.6%
Q4 24
-101.1%
-285.2%
Q3 24
-58.1%
-86.0%
Q2 24
12.1%
-491.0%
Q1 24
-64.1%
-861.1%
EPS (diluted)
MLSS
MLSS
NVVE
NVVE
Q4 25
$-69.41
Q3 25
$-0.01
$-0.24
Q2 25
Q1 25
$-3.88
Q4 24
$-1050.64
Q3 24
$-0.02
$-2.47
Q2 24
$-6.70
Q1 24
$-16.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MLSS
MLSS
NVVE
NVVE
Cash + ST InvestmentsLiquidity on hand
$1.1M
$5.5M
Total DebtLower is stronger
$1.7M
Stockholders' EquityBook value
$2.8M
$-1.7M
Total Assets
$7.8M
$17.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MLSS
MLSS
NVVE
NVVE
Q4 25
$1.1M
$5.5M
Q3 25
$1.3M
$939.4K
Q2 25
$1.3M
Q1 25
$2.2M
$1.2M
Q4 24
$3.3M
$371.5K
Q3 24
$4.8M
$325.2K
Q2 24
$5.8M
$1.4M
Q1 24
$5.0M
$5.3M
Total Debt
MLSS
MLSS
NVVE
NVVE
Q4 25
$1.7M
Q3 25
$3.0M
Q2 25
Q1 25
$4.8M
Q4 24
$5.5M
Q3 24
$2.4M
Q2 24
Q1 24
Stockholders' Equity
MLSS
MLSS
NVVE
NVVE
Q4 25
$2.8M
$-1.7M
Q3 25
$2.5M
$-1.4M
Q2 25
$3.3M
Q1 25
$4.5M
$-3.2M
Q4 24
$5.8M
$-1.3M
Q3 24
$7.2M
$3.0M
Q2 24
$8.0M
$3.3M
Q1 24
$7.5M
$6.6M
Total Assets
MLSS
MLSS
NVVE
NVVE
Q4 25
$7.8M
$17.4M
Q3 25
$8.5M
$16.8M
Q2 25
$8.1M
Q1 25
$9.1M
$16.5M
Q4 24
$9.8M
$16.8M
Q3 24
$11.2M
$18.3M
Q2 24
$12.0M
$18.5M
Q1 24
$11.4M
$23.5M
Debt / Equity
MLSS
MLSS
NVVE
NVVE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.81×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MLSS
MLSS
NVVE
NVVE
Operating Cash FlowLast quarter
$-226.1K
$-4.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MLSS
MLSS
NVVE
NVVE
Q4 25
$-226.1K
$-4.3M
Q3 25
$81.8K
$-5.1M
Q2 25
$-1.8M
Q1 25
$-1.0M
$-1.8M
Q4 24
$-1.5M
$-3.5M
Q3 24
$-973.9K
$-3.5M
Q2 24
$783.7K
$-4.0M
Q1 24
$-1.2M
$-4.7M
Free Cash Flow
MLSS
MLSS
NVVE
NVVE
Q4 25
Q3 25
$-5.1M
Q2 25
Q1 25
$-1.8M
Q4 24
$-3.5M
Q3 24
$-3.5M
Q2 24
$-4.0M
Q1 24
$-4.8M
FCF Margin
MLSS
MLSS
NVVE
NVVE
Q4 25
Q3 25
-317.6%
Q2 25
Q1 25
-194.9%
Q4 24
-196.0%
Q3 24
-182.9%
Q2 24
-501.7%
Q1 24
-611.2%
Capex Intensity
MLSS
MLSS
NVVE
NVVE
Q4 25
0.0%
Q3 25
0.2%
Q2 25
Q1 25
1.3%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
1.5%
Q1 24
5.2%
Cash Conversion
MLSS
MLSS
NVVE
NVVE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
3.50×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MLSS
MLSS

Segment breakdown not available.

NVVE
NVVE

Engineering Services$1.1M57%
Other$838.4K43%

Related Comparisons